Microsoft word - 00000000000003231472_1355336437895
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
1. Chemical Product and Company Identification
ACRIFIX® CA 0020
Evonik CYRO LLC 299 Jefferson Road
Parsippany, NJ 07054-0677
+1-973-929-8291
Product
24 Hour Emergency Number, CHEMTREC 1-800-424-9300
(TM) indicates trademark
Product Use: catalyst for polymerization adhesive, Industrial use
2. Composition/Information on Ingredients
This material is classified as hazardous under OSHA regulations.
CAS Reg. No. Weight %
oxydipropyl dibenzoate
dibenzoyl peroxide; benzoyl peroxide
NJTSR # 56705700001-6904P See Section 8, Exposure Controls/Personal Protection
3. Hazards Identification
Emergency Overview
colourless to yellowish, clear
Danger! Organic Peroxide.
May cause fire.
May cause allergic skin reaction.
May cause eye irritation.
Container may explode when heated.
Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic
environment.
Primary Routes of Exposure
Skin contact Eye contact
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
Potential Health Effects
Inhalation
No hazard expected in normal use.
Eye Contact
Direct contact with material can cause the following: - slight irritation
Skin Contact
Direct contact with material can cause the following: - slight irritation - sensitization - allergic dermatitis
Ingestion
Swallowing of material can cause the following: - dizziness - headache - nausea - vomiting
Potential Environmental Effects
See SECTION 12, Ecological Information
4. First Aid Measures
First Aid Procedures
Inhalation
Remove to fresh air. Obtain medical attention if irritation develops.
Eye Contact
In case of contact, immediately flush eyes with plenty of water. Consult a physician if irritation persists.
Skin Contact
Immediately wash skin with soap and plenty of water. Remove contaminated clothing and shoes. Get medical attention. Wash clothing before reuse.
Ingestion
Only induce vomiting if directed by a physician. Get medical attention. Never give anything by mouth to an unconscious person.
Note to Physician
Causes eye irritation. , Skin Sensitisation, Allergic appearance
Treat symptomatically.
5. Fire-Fighting Measures
Flash point
Ignition temperature
not spontaneously flammable
Lower explosion limit
Upper explosion limit
OSHA Flammability Classification
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
Unusual Hazards
May be released in case of fire: carbon monoxide, carbon dioxide, organic products of decomposition. -
Extinguishing Media
Use the following extinguishing media when fighting fires involving this material: dry chemical - carbon dioxide - alcohol-resistant foam
Fire Fighting Procedures
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective gear. Cool with water spray.
6. Accidental Release Measures
Procedures
Remove sources of ignition and ventilate area. Absorb spill with inert material and place in a chemical waste container. Obey relevant local, state, provincial and federal laws and regulations. Do not contaminate any lakes, streams, ponds, groundwater or soil. Use personal protective equipment. See Material Safety Data Sheet section 8, Exposure Controls/Personal Protection.
7. Handling and Storage
Handling
Avoid contact with eyes, skin and clothing. Wash thoroughly after handling. Use with adequate
ventilation. The need for grounding and bonding of containers in accordance with OSHA 29 CFR
1910.106 and NFPA 77 should be assessed for all product transfers.
Handling
Do not return residues to the storage containers.
Store in a cool, dry place. Keep container closed when not in use. Do not store together with accelerators.
8. Exposure Controls/Personal Protection
Exposure Limit Information
DIBENZOYL PEROXIDE
(CAS Number 94-36-0 )
Carcinogen designation(s) USA: IARC-3; TLV-A4
Occupational Exposure Values :
OEL-TWA (Alberta)
OEL-STEL (Alberta)
OEL-TWA (British Columbia)
OEL-STEL (British Columbia)
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
OEL-TWA (Ontario)
OEL-STEL (Ontario)
OEL-TWA (Quebec)
OEL-STEL (Quebec)
OEL-TWA (Mexico)
OEL-STEL (Mexico)
OXYDIPROPYL DIBENZOATE
(CAS Number 27138-31-4 )
Occupational Exposure Values :
OEL-TWA (North Carolina)
OEL-STEL (North Carolina)
OEL-TWA (Alberta)
OEL-STEL (Alberta)
OEL-TWA (British Columbia)
OEL-STEL (British Columbia)
OEL-TWA (Ontario)
OEL-STEL (Ontario)
OEL-TWA (Quebec)
OEL-STEL (Quebec)
OEL-TWA (Mexico)
OEL-STEL (Mexico)
Engineering Controls (Ventilation)
Use process enclosures, local exhaust ventilation or other engineering controls to control airborne exposure.
Respiratory Protection
A respiratory protection program that meets OSHA 1910.134 and ANSI Z88.2 or applicable
federal/provincial requirements must be followed whenever workplace conditions warrant respirator use. NIOSH's "Respirator Decision Logic" may be useful in determining the suitability of various types of respirators.
Eye Protection
Use safety glasses (ANSI Z87.1 or approved equivalent).
Skin Protection
On handling of larger quantities: face mask, chemical-resistant boots and apron
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
Hand Protection
The glove(s) listed below may provide protection against permeation. Gloves of other chemically resistant materials may not provide adequate protection: nitrile rubber gloves Chemical-resistant gloves should be worn whenever this material is handled. Gloves should be removed and replaced immediately if there is any indication of degradation or chemical breakthrough. For each work-place a suitable glove type has to be selected.
Other Protective Equipment
A safety shower and eye wash fountain should be readily available. To identify additional Personal Protective Equipment (PPE) requirements, it is recommended that a hazard assessment in accordance with the OSHA PPE Standard (29CFR1910.132) be conducted before using this product.
9. Physical and Chemical Properties
Appearance
colourless to yellowish, clear
Physical
Flash point
pH-value
Viscosity (dynamic)
ca. 180 mPa.s at 20 °C / (Brookfield )
Specific gravity (water = 1)
1.12 g/cm3 at 20 °C / 68 °F
Vapor density (air = 1)
Vapor pressure
Solidification Point
Boiling Point
Solubility in water
scarcely soluble
n-Octanol/water partition
coefficient
Evaporation rate
Odor threshold
Further information
See Section 5, Fire Fighting Measures
10. Stability and Reactivity
Stability
Danger of decomposition under influence of heat. SADT ( = Self Accelerating Decomposition Temperature) of dibenzoylperoxide: 60 °C (140 °F)
Conditions To Avoid
Avoid high temperatures and sources of ignition. Ultraviolet light.
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
Incompatibility With Other Materials
Violent decomposition of the peroxide occurs on direct contact with accelerators, e.g. heavy metal salts, tertiary amines, conc. mineral acids and alkali, and reducing agents.
Hazardous Decomposition Products
None when used as directed. With thermal decomposition, flammable fumes arise which are irritating to the eyes and respiratory organs, predominantly consisting of: carbon oxides, hydrocarbons
Hazardous Polymerization
Risk of self-accelerating, exothermic decomposition with the development of oxygen on contact with incompatible substances.
11. Toxicological Information
Acute Oral Toxicity
Related to substance: dibenzoyl peroxide
Related to substance: Oxidipropyldibenzoate
Irritant Effect on the Skin
Contact with skin may cause irritations. Related to substance: product
Irritant Effect on the Eyes
Contact with the eyes may cause irritation. Related to substance: product
May cause sensitisation by skin contact.
Related to substance: dibenzoyl peroxide
Further Information on Toxicology
Avoid skin and eye contact and inhalation of product vapours/aerosols.
12. Ecological Information
Information on Elimination (Persistence and Degradability)
Bioaccumulation
Ecotoxicological Effect
Fish Toxicity
LC50 Poecilia reticulata, 96 h
Related to substance: dibenzoyl peroxide
Daphnia Toxicity
EC50 Daphnia magna, 48 h
Related to substance: dibenzoyl peroxide
Bacteria Toxicity
Related to substance: dibenzoyl peroxide
EC50 Pseudomonas putida
Related to substance: Oxidipropyldibenzoate
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
Further Information on Ecology
Prevent substance from entering soil, natural bodies of water and sewer systems.
13. Disposal Considerations
Procedures
Waste must be disposed of in accordance with federal, state and local regulations. Incineration is the preferred method. CYRO encourages the recycle, recovery and reuse of materials, where permitted, as an alternate to disposal as a waste.
14. Transport Information
US DOT Hazard Classification
Proper Shipping Name ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S.
Name (contains Oxidipropyldibenzoat)
Canadian TDG Classification
Refer to the classification US DOT
Shipment by sea IMDG/GGVSee UN
Proper Shipping Name ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S.
(contains Oxidipropyldibenzoat)
Oxidipropyldibenzoat
Air transport ICAO/IATA UN
Proper Shipping Name ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S.
(contains Oxidipropyldibenzoat)
15. Regulatory Information
INVENTORY INFORMATION
preregistered, registered or exempted
listed or exempted
listed or exempted
listed or exempted
listed or exempted
listed or exempted
listed or exempted
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
listed or exempted
US FEDERAL REGULATORY INFORMATION
Component / CASRN
dibenzoyl peroxide; benzoyl peroxide /
COMPONENT CLASSIFICATION UNDER CLEAN AIR ACT SECTION 112
Component / CASRN
PRODUCT CLASSIFICATION UNDER SECTION 311/312 OF SARA (40CFR370)
ACUTE, CHRONIC, REACTIVE,
US STATE REGULATORY INFORMATION
Pennsylvania Massachusetts
Component / CASRN
Proposition 65 Proposition 65
dibenzoyl peroxide; benzoyl peroxide /
oxydipropyl dibenzoate /
CANADIAN REGULATION
This product has been classified in accordance with the hazard criteria of the Controlled Products
Regulation and the MSDS contains all information required by the Controlled Products Regulations.
This is a controlled product.
WHMIS: D2B, C, B3
Component / CASRN
dibenzoyl peroxide; benzoyl peroxide /
16. Other Information
Recommended restriction(s) for use
Material Safety Data Sheet
Status: 06/18/2012
ACRIFIX® CA 0020
HMIS Hazard Ratings
NFPA Hazard Ratings
0 = insignificant
N = no rating for powders
N = no rating for powders
* = chronic health hazard
This MSDS was prepared in accordance with ANSI Z400.1-1998.
Places marked by have been amended from the last version.
This information and all technical and other advice are based on Evonik's present knowledge and experience. However, Evonik assumes no
liability for such information or advice, including the extent to which such information or advice may relate to third party intellectual property
rights. Evonik reserves the right to make any changes to information or advice at any time, without prior or subsequent notice. EVONIK
DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS OR IMPLIED, AND SHALL HAVE NO LIABILITY FOR,
MERCHANTABILITY OF THE PRODUCT OR ITS FITNESS FOR A PARTICULAR PURPOSE (EVEN IF EVONIK IS AWARE OF SUCH
PURPOSE), OR OTHERWISE. EVONIK SHALL NOT BE RESPONSIBLE FOR CONSEQUENTIAL, INDIRECT OR INCIDENTAL DAMAGES
(INCLUDING LOSS OF PROFITS) OF ANY KIND. It is the customer's sole responsibility to arrange for inspection and testing of all products by
qualified experts. Reference to trade names used by other companies is neither a recommendation nor an endorsement of the corresponding
product, and does not imply that similar products could not be used.
Date of printing : 12/12/2012
Source: http://ruplo.nl/wp-content/uploads/2015/06/acrifix-ca-0020.pdf
NCFE Level 2Certificate in Understanding the Safe Handling of Medication in Health and Social Care Section 1: Understand medication and prescriptions This section will introduce the types of medicine you will come across in the work environment. You will also look at legislation and guidance about medicines. The different types of medicine available and why they
Visit www.HyponatremiaCME.org for additional cases and activities Clinical Perspectives in As a physician scientist who has been studying and treating hyponatremic patients for the past 30 years, I am pleased to introduce this case-based continuing medical education publication and associated Web-based interactive learning program, Clinical Perspectives